Continuing Education Activity

The medulla oblongata forms the caudal portion of the brainstem and plays a critical role in motor, sensory, and autonomic function. Medial medullary syndrome, also known as Dejerine syndrome, results from infarction of the medial medulla, most commonly due to atherothrombotic occlusion of the paramedian branches of the anterior spinal artery or vertebral artery. This course examines stroke lesions that affect key structures, including the lateral corticospinal tract, medial lemniscus, and hypoglossal nerve, leading to contralateral limb weakness, contralateral loss of proprioception and vibration sense, and ipsilateral tongue deviation, as well as risk factors that mirror those of ischemic stroke, such as hypertension, diabetes, dyslipidemia, smoking, and cardioembolic sources. Diagnosis 

This activity reviews the anatomy, vascular supply, clinical presentation, evaluation, and management of medial medullary stroke, as well as the diagnosis of the resulting syndrome, which relies on careful neurological examination and neuroimaging. Participants will also gain an understanding of stroke recognition, localization of brainstem lesions, appropriate use of imaging and ancillary testing, and acute and postacute management strategies to reduce morbidity, mortality, and complications through timely, coordinated care. This activity for healthcare professionals is designed to enhance the learner's competence in identifying medial medullary stroke, performing the recommended evaluation, and implementing an appropriate interprofessional approach when managing this condition. 

Objectives:

• Identify the vascular supply of the medulla oblongata relevant to medial medullary stroke.
• Assess patients for the clinical signs of medial medullary (Dejerine) syndrome.
• Interpret neurological examination findings to localize brainstem lesions accurately.
• Collaborate with interprofessional healthcare team members to improve care coordination and outcomes in patients with medial medullary stroke.

Access free multiple choice questions on this topic.

Introduction

The medulla oblongata, commonly referred to as the medulla, constitutes a critical portion of the brainstem. It connects rostrally with the pons at the pontomedullary junction and caudally with the spinal cord at the level of the C1 vertebra. Key medial structures within the medulla include the pyramid, medial lemniscus, hypoglossal nucleus, and medial longitudinal fasciculus. Blood supply to these medial medullary structures originates from the paramedian branches of the anterior spinal artery, which itself arises from the vertebral artery, a branch of the subclavian artery. It may also be supplied by paramedian perforators arising from the vertebral artery.[1]

Medial medullary syndrome, also called Dejerine syndrome, is the clinical manifestation of infarction of the medial medulla. Joseph Jules Dejerine first described this syndrome in 1915, highlighting the clinical consequences of medial medullary lesions and establishing the foundation for understanding this distinct brainstem stroke pattern.[2]

Etiology

Medial medullary stroke most commonly results from atherothrombotic occlusion of the paramedian branches of the anterior spinal artery, the vertebral artery, or the basilar artery. Major risk factors include dyslipidemia, hypertension, diabetes, and smoking. Mechanistically, medial medullary infarction most often reflects vertebral artery atherosclerotic disease or branch atheromatous disease affecting paramedian perforators, and less commonly embolic occlusion.[1] Vertebral artery dissection also represents a significant cause of medial medullary stroke, particularly in younger patients, highlighting the need for careful vascular evaluation in this population. Additional contributing factors encompass atrial fibrillation, atrial septal defect, patent foramen ovale, migraine, and Takayasu arteritis. [3][4][5]

Epidemiology

Stroke ranks as the second-leading cause of death worldwide and represents a major source of long-term disability. In the United States, nearly 800,000 patients experience an acute stroke annually, with 83% classified as ischemic strokes. Vertebrobasilar artery occlusion, affecting the posterior circulation, accounts for approximately 20% to 25% of ischemic strokes. Posterior circulation strokes can produce a variety of neurological syndromes, with medial medullary syndrome representing a rare subset.[6][7] Medial medullary stroke contributes to approximately 1% of all cerebral infarctions. Lesions typically occur unilaterally, although bilateral involvement has been documented in certain cases.[8][9]

Pathophysiology

Medial medullary syndrome is classically caused by ischemic infarction in the paramedian medial medulla; however, a similar clinical phenotype can rarely result from other focal medial medullary lesions, including hemorrhage (eg, cavernous malformation–related), demyelination, infection (medullary abscess), or neoplasm. Key involved structures include the medullary pyramid (corticospinal fibers), the medial lemniscus, and the hypoglossal nucleus and fascicles, producing contralateral weakness, contralateral loss of vibration and proprioception, and ipsilateral tongue weakness.[10]

The lateral corticospinal tract controls the voluntary movement of the contralateral limbs of the body. The medial lemniscus receives sensory (vibration, fine touch, and proprioception) input from the contralateral nucleus cuneatus or nucleus gracilis and sends this signal to the sensory cortex of the brain.[11][12] Due to the involvement of the caudal medulla, hypoglossal nerve (12th cranial nerve) damage may occur. The hypoglossal nerve supplies the intrinsic and extrinsic muscles of the tongue except for palatoglossus.

The hypoglossal nerve supplies the function of each of the following muscles:

• Genioglossus: Protrude the tongue forward from the root
• Hyoglossus: Retracts and depresses the tongue
• Styloglossus: Draws the tongue upward
• Intrinsic muscles (transversus, verticalis, superior/inferior longitudinalis): By curving, shortening, and narrowing the tongue, they change the shape of the tongue [13][14]

History and Physical

Clinical Features

The classic clinical triad of medial medullary syndrome consists of ipsilateral hypoglossal palsy with tongue deviation, contralateral hemiparesis, and contralateral loss of deep sensation involving vibration and proprioception.[15] However, this triad is observed in only a minority of patients. Contralateral paralysis of the upper and lower limbs due to lateral corticospinal tract involvement represents a common clinical finding.[16][17]

Involvement of the medial lemniscus may produce contralateral reduction in proprioception, vibration, and fine touch sensation. Some patients report paresthesias or, less frequently, dysesthesias affecting the contralateral trunk and lower limb. Many patients with sensory complaints lack objective evidence of impaired position, touch, or vibration sense. In certain cases, mild loss of position and vibration sensation, with associated proprioceptive dysfunction, is observed in the contralateral foot.[18]

Ipsilateral tongue deviation results from damage to the ipsilateral hypoglossal nerve, reflecting a lower motor neuron lesion. Dysphagia occurs less frequently than in lateral medullary syndrome but appears more commonly in bilateral medial medullary infarction.[19] A review of 28 cases of bilateral medial medullary infarction identified 11 patients with dysphagia or palatal palsy.[20]

Evaluation

The evaluation of medial medullary stroke requires a focused clinical history, a thorough physical examination, and appropriate diagnostic testing. Assessment of vascular and systemic risk factors should address dyslipidemia, hypertension, diabetes, smoking, atrial fibrillation, atrial septal defect, migraine, and Takayasu arteritis, as these conditions increase the likelihood of ischemic stroke involving the medial medulla. Electrocardiography (ECG) assists in excluding underlying atrial fibrillation. Additional baseline investigations should include serum glucose, serum electrolytes, and a fasting lipid panel.

A comprehensive neurological examination plays a central role in the evaluation of medial medullary stroke, as medial medullary syndrome remains largely a clinical diagnosis supported by targeted findings. Neuroimaging forms a critical component of diagnostic evaluation. Both computed tomography (CT) and magnetic resonance imaging (MRI) support diagnosis, though MRI provides superior visualization of medial medullary lesions. Posterior cranial fossa structures often appear poorly defined on computed tomography because of obscuration by surrounding bony anatomy.

Diffusion-weighted (DWI) and T2-weighted sequences typically demonstrate a hyperintense lesion within the medial medulla.[3][21] CT angiography or magnetic resonance angiography of the head and neck allows detailed evaluation of vertebral artery pathology, including dissection, and facilitates identification of posterior circulation large-vessel occlusion involving the vertebrobasilar or basilar arteries.

Treatment / Management

Management of medial medullary stroke follows established principles for acute ischemic stroke care. Rapid patient evaluation supports timely diagnosis and treatment decisions, which directly influence outcomes. Care delivered within a dedicated stroke center reduces both mortality and morbidity through coordinated, protocol-driven management.

Prehospital Management

Prehospital care of medial medullary stroke focuses on stabilization and early recognition of stroke. Airway, breathing, and circulation require prompt assessment and support, with supplemental oxygen administered to maintain oxygen saturation above 94%. Additionally, cardiac monitoring should begin when feasible, intravenous access should follow local protocol, and capillary blood glucose measurement should guide immediate correction of hypo- or hyperglycemia. Patients should remain NPO (nothing by mouth) and undergo expedited transport to the nearest appropriate stroke center.

Intrahospital Management Steps

Intrahospital management of medial medullary stroke includes intravenous recombinant tissue plasminogen activator administration within 3 or 4.5 hours of symptom onset for eligible patients. Therapeutic benefit depends strongly on time to treatment, supporting early initiation. Following thrombolysis, close monitoring for 24 hours within an intensive care or dedicated stroke unit remains essential.

Endovascular options include intra-arterial fibrinolysis, mechanical clot aspiration with the Penumbra system, and acute angioplasty with stenting, typically reserved for large-vessel occlusion. Endovascular thrombectomy is particularly relevant for suspected basilar artery occlusion, with randomized trials, eg, ATTENTION and BAOCHE, demonstrating improved 90-day functional outcomes compared with best medical therapy in appropriately selected patients.[22][23][24]

General Therapy

General supportive therapy includes isotonic fluid administration, with avoidance of hypotonic solutions because of cerebral edema risk. Cerebral autoregulation impairment within infarcted tissue necessitates cautious blood pressure management. Antihypertensive therapy should begin when blood pressure exceeds 220/120 or when patients receive intravenous thrombolysis. For thrombolysis eligibility, blood pressure must be reduced to below 185/110 mm Hg before treatment and maintained at or below 180/105 mm Hg during the first 24 hours after therapy, with gradual lowering emphasized.

Glycemic control within normal limits remains essential, alongside treatment of coexisting medical conditions. Swallowing assessment should precede oral intake or medication administration. Suspected pneumonia warrants prompt antibiotic therapy. Subcutaneous anticoagulants support deep vein thrombosis prevention in immobilized patients. Avoiding routine indwelling urinary catheters reduces the risk of catheter-associated urinary tract infections. Early initiation of physical and occupational therapy supports recovery and rehabilitation.

Potential Discharge Medications

Discharge medications depend on stroke etiology. Oral anticoagulation remains appropriate for cardioembolic sources (eg, atrial fibrillation). Antiplatelet therapy with clopidogrel, aspirin, or a dipyridamole and aspirin combination addresses noncardioembolic mechanisms.[25] Statin therapy supports dyslipidemia management and secondary stroke prevention.

Differential Diagnosis

Differential diagnoses that should be also be considered when evaluating patients with clinical features of medial medullary stroke include:

• Advanced amyotrophic lateral sclerosis (ALS)
• Hemimedullary infraction
• Hypoglossal nerve injury
• Brown-Sequard syndrome
• Intracranial tumor
• Posterior cord syndrome (PCS)

Prognosis

As the brain is permanent tissue, any injury to the brain is not completely reversible. With the advancement of medical science, nowadays, early diagnosis and early initiation of treatment, and the use of rehabilitative services, medial medullary stroke and associated clinical manifestations have a fair prognosis. If the patient presents with severe hemiparesis and hemi-sensory loss, then residual hemiparesis and sensory loss may remain for the lifetime. A review of 26 previously reported cases that had bilateral lesions and presented with lingual paresis, quadriplegia, and respiratory symptoms had a bad prognosis.[26]

Complications

The most common complications of medial medullary stroke are deep vein thrombosis (DVT) and pulmonary embolism. Patients may develop severe dysphagia, especially those with bilateral medial medullary stroke. Patients can develop aspiration pneumonia. If immediate management is not initiated, then the condition can be fatal. Pulmonary embolism can present with sudden onset dyspnea, which can lead to death. Patients with hemiplegia may develop bedsores. Infections can further complicate bedsores and may progress to septicemia and death.[20][27]

Postoperative and Rehabilitation Care

Early rehabilitation is helpful for patients who have had a stroke. Studies have shown that rehabilitation within 24 hours of the stroke event is not beneficial, compared to the usual stroke unit care. So rehabilitation within 24 hours of the stroke event should be avoided.[28]

Deterrence and Patient Education

Deterrence and patient education play a central role in reducing recurrence and long-term complications following medial medullary stroke. After clinical stabilization, secondary prevention strategies should begin promptly and involve both the patient and family to reinforce understanding and adherence. Education should emphasize recognition of stroke warning signs, the importance of timely emergency evaluation, and adherence to prescribed antithrombotic, antihypertensive, lipid-lowering, and glucose-lowering therapies. Clear communication regarding follow-up care, rehabilitation goals, and swallowing precautions supports recovery while reducing complications such as aspiration and immobility-related events.

Focused counseling on modifiable vascular risk factors remains essential to decrease secondary stroke risk. Smoking cessation should receive strong emphasis, along with strict glycemic control in patients with diabetes and consistent blood pressure management. Dietary counseling should promote a low-fat, heart-healthy diet, combined with weight reduction strategies when appropriate. Engaging patients in lifestyle modification plans and coordinating education with nursing, rehabilitation, and primary care teams strengthens long-term risk reduction and supports sustained neurologic and functional outcomes.

Pearls and Other Issues

Accurate localization remains central to the recognition of medial medullary lesions. The combination of contralateral hemiparesis with ipsilateral tongue deviation provides a strong localizing sign of medial medullary involvement. Facial musculature typically remains spared, and the presence of facial weakness suggests a pontine rather than a medullary lesion, further refining brainstem localization. Careful examination of tongue movement supports diagnosis, as protrusion often reveals deviation toward the side of the lesion.

Sensory deficits in medial medullary syndrome demonstrate a selective pattern. Contralateral loss of vibration and proprioception commonly occurs, while pain and temperature sensation usually remain intact, distinguishing this syndrome from lateral medullary involvement. Clinical presentation often lacks the complete classic triad, as partial or evolving symptoms frequently occur and should not exclude the diagnosis. Bulbar manifestations such as dysarthria or dysphagia require early recognition and prompt swallowing evaluation to reduce aspiration pneumonia risk. Neuroimaging selection influences diagnostic accuracy, as early computed tomography may appear normal; magnetic resonance imaging with diffusion-weighted sequences provides greater sensitivity when clinical suspicion remains high. Early engagement of physical, occupational, and speech therapy supports functional recovery and improves long-term outcomes despite initial neurologic deficits.

Enhancing Healthcare Team Outcomes

Medial medullary stroke represents a rare posterior circulation ischemic stroke caused by infarction of the medial medulla. Involvement of the corticospinal tract, medial lemniscus, and hypoglossal nerve produces characteristic findings such as contralateral hemiparesis, selective sensory deficits, and ipsilateral tongue deviation. Prompt recognition, accurate neuroanatomic localization, and timely imaging with magnetic resonance techniques support early diagnosis and initiation of evidence-based stroke management to reduce morbidity, mortality, and long-term disability.

Optimal care requires coordinated interprofessional collaboration across all levels of healthcare delivery. Emergency medical services initiate early recognition and rapid transport, while physicians, general practitioners, and advanced practitioners perform focused neurological assessment, activate stroke protocols, and guide acute treatment decisions. Neurologists and neurology specialist nurses coordinate ongoing monitoring, patient education, and communication among team members. Nurses play a central role in neurologic surveillance, dysphagia screening, and complication prevention. Pharmacists evaluate medication selection, dosing, and drug–drug interactions while supporting secondary prevention strategies. Physical, occupational, and speech therapists contribute to rehabilitation planning and functional recovery. Effective communication and shared responsibility across disciplines enhance patient-centered care, safety, outcomes, and overall team performance in managing medial medullary stroke and its associated clinical manifestations.[29][30]

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Kim JS, Han YS. Medial medullary infarction: clinical, imaging, and outcome study in 86 consecutive patients. Stroke. 2009 Oct;40(10):3221-5. [PubMed: 19628797]

2.

Sawada H, Seriu N, Udaka F, Kameyama M. Magnetic resonance imaging of medial medullary infarction. Stroke. 1990 Jun;21(6):963-6. [PubMed: 2349601]

3.

Fukuoka T, Takeda H, Dembo T, Nagoya H, Kato Y, Deguchi I, Maruyama H, Horiuchi Y, Uchino A, Yamazaki S, Tanahashi N. Clinical review of 37 patients with medullary infarction. J Stroke Cerebrovasc Dis. 2012 Oct;21(7):594-9. [PubMed: 21376629]

4.

Deshpande A, Chandran V, Pai A, Rao S, Shetty R. Bilateral medial medullary syndrome secondary to Takayasu arteritis. BMJ Case Rep. 2013 Aug 13;2013 [PMC free article: PMC3762468] [PubMed: 23943806]

5.

Sweeney BJ, Rossor MN. Medial medullary syndrome associated with patent foramen ovale in a weightlifter. Eur Neurol. 1996;36(6):391. [PubMed: 8954309]

6.

Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018 Apr;38(2):208-211. [PubMed: 29791947]

7.

Go S. Posterior Circulation Ischemic Stroke. Mo Med. 2015 May-Jun;112(3):192-6. [PubMed: 26168589]

8.

Patwardhan S, Pawar SS, Gavali P. Bilateral medial medullary syndrome-a rare case report. Acta Neurol Belg. 2024 Jun;124(3):1055-1057. [PubMed: 38001369]

9.

Zegg M, Spicher A, Pfausler B, Nowosielski M, Krappinger D. Bilateral medial medullary syndrome following anterior screw fixation of type 2 odontoid fracture, a case report of two patients. Spinal Cord Ser Cases. 2021 Nov 20;7(1):101. [PMC free article: PMC8604953] [PubMed: 34799551]

10.

Khiralla A, Giotta Lucifero A, Al-Mefty O. Median medullary perforators: Anatomical, surgical, and clinical significance in foramen magnum meningiomas. Neurosurg Rev. 2025 Oct 16;48(1):710. [PubMed: 41099782]

11.

Cleland BT, Madhavan S. Ipsilateral motor pathways to the lower limb after stroke: Insights and opportunities. J Neurosci Res. 2021 Jun;99(6):1565-1578. [PMC free article: PMC8085051] [PubMed: 33665910]

12.

Willis WD, Westlund KN. The role of the dorsal column pathway in visceral nociception. Curr Pain Headache Rep. 2001 Feb;5(1):20-6. [PubMed: 11252134]

13.

Javed K, Reddy V, Lui F. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 24, 2023. Neuroanatomy, Lateral Corticospinal Tract. [PubMed: 30521239]

14.

Lin HC, Barkhaus PE. Cranial nerve XII: the hypoglossal nerve. Semin Neurol. 2009 Feb;29(1):45-52. [PubMed: 19214932]

15.

Gan R, Noronha A. The medullary vascular syndromes revisited. J Neurol. 1995 Mar;242(4):195-202. [PubMed: 7798117]

16.

Caplan L. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture-2000. Stroke. 2000 Aug;31(8):2011-23. [PubMed: 10926972]

17.

Tyler KL, Sandberg E, Baum KF. Medical medullary syndrome and meningovascular syphilis: a case report in an HIV-infected man and a review of the literature. Neurology. 1994 Dec;44(12):2231-5. [PubMed: 7991103]

18.

Westlund KN. Visceral nociception. Curr Rev Pain. 2000;4(6):478-87. [PMC free article: PMC7879461] [PubMed: 11060594]

19.

Kwon M, Lee JH, Kim JS. Dysphagia in unilateral medullary infarction: lateral vs medial lesions. Neurology. 2005 Sep 13;65(5):714-8. [PubMed: 16157904]

20.

Paliwal VK, Kalita J, Misra UK. Dysphagia in a patient with bilateral medial medullary infarcts. Dysphagia. 2009 Sep;24(3):349-53. [PubMed: 19115072]

21.

Tokuoka K, Yuasa N, Ishikawa T, Takahashi M, Mandokoro H, Kitagawa Y, Takagi S. A case of bilateral medial medullary infarction presenting with "heart appearance" sign. Tokai J Exp Clin Med. 2007 Sep 20;32(3):99-102. [PubMed: 21318946]

22.

Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H., American Heart Association Stroke Council. Council on Cardiovascular Nursing. Council on Peripheral Vascular Disease. Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. [PubMed: 23370205]

23.

Bogenschutz KM, Fisher DS, Wright GW. Acute ischemic stroke: A guideline-based overview of evaluation and management. JAAPA. 2025 May 01;38(5):13-20. [PubMed: 40197996]

24.

Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, Wen C, Zhou P, Chen W, Zeng G, Li Y, Ma Z, Yu C, Su J, Zhou Z, Chen Z, Liao G, Sun Y, Ren Y, Zhang H, Chen J, Yue X, Xiao G, Wang L, Liu R, Liu W, Liu Y, Wang L, Zhang C, Liu T, Song J, Li R, Xu P, Yin Y, Wang G, Baxter B, Qureshi AI, Liu X, Hu W., ATTENTION Investigators. Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion. N Engl J Med. 2022 Oct 13;387(15):1361-1372. [PubMed: 36239644]

25.

Rahman M, Siddik AB. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jan 13, 2023. Anatomy, Arterioles. [PubMed: 32310381]

26.

Kim JS, Kim HG, Chung CS. Medial medullary syndrome. Report of 18 new patients and a review of the literature. Stroke. 1995 Sep;26(9):1548-52. [PubMed: 7660396]

27.

Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA., American Heart Association Stroke Council. Council on Cardiovascular and Stroke Nursing. Council on Clinical Cardiology. Council on Functional Genomics and Translational Biology. Council on Hypertension. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Dec;45(12):3754-832. [PMC free article: PMC5020564] [PubMed: 25355838]

28.

Connell LA, Lincoln NB, Radford KA. Somatosensory impairment after stroke: frequency of different deficits and their recovery. Clin Rehabil. 2008 Aug;22(8):758-67. [PubMed: 18678576]

29.

Clarke DJ, Forster A. Improving post-stroke recovery: the role of the multidisciplinary health care team. J Multidiscip Healthc. 2015;8:433-42. [PMC free article: PMC4590569] [PubMed: 26445548]

30.

Waldman A, Tadi P, Khan Suheb MZ, Rawal AR. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Oct 29, 2023. Stroke Center Certification(Archived) [PubMed: 30571013]

Disclosure: Abu Bakar Siddik declares no relevant financial relationships with ineligible companies.

Disclosure: Jagkirat Singh declares no relevant financial relationships with ineligible companies.

Disclosure: Vikas Gupta declares no relevant financial relationships with ineligible companies.